Narra R - Search Results

1

Diagnosing Primary Hemophagocytic Lymphohistiocytosis in an Adult: A Case Report.

Smith KK, Hobbs LM, Narra R. Smith KK, et al. Among authors: narra r. Cureus. 2024 Nov 2;16(11):e72884. doi: 10.7759/cureus.72884. eCollection 2024 Nov. Cureus. 2024. PMID: 39624524 Free PMC article.

2

Impact of induction regimens intensity and allogeneic stem cell transplantation on survival of patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: A multi-institutional study.

Badar T, Narra R, Mims AS, Heckman MG, Shallis RM, Fahad S, Hunter C, Kota V, Othman TA, Jonas B, Desai S, de Camargo Correia GS, Patel A, DuVall AS, Palmisiano N, Curran E, Omer Z, Advani A, Atallah E, Litzow M. Badar T, et al. Among authors: narra r. Am J Hematol. 2024 Dec;99(12):2388-2391. doi: 10.1002/ajh.27475. Epub 2024 Sep 10. Am J Hematol. 2024. PMID: 39253997

3

Evaluating population-level outcomes in Chronic Lymphocytic leukemia in the era of novel therapies using the SEER registry.

Muthiah C, Narra R, Atallah E, Juan W, Szabo A, Guru Murthy GS. Muthiah C, et al. Among authors: narra r. Leuk Res. 2024 May;140:107496. doi: 10.1016/j.leukres.2024.107496. Epub 2024 Mar 22. Leuk Res. 2024. PMID: 38547577

4

Post-relapse survival in Waldenstrom macroglobulinemia patients experiencing therapy failure following autologous transplantation.

Ahmed S, Zhao Q, Hanel W, Qazilbash MH, Patel K, Narra R, Kansagra A, Iqbal M, Awan FT, Christian B, Jaglowski SM, Kharfan-Dabaja MA, Hamadani M, Epperla N. Ahmed S, et al. Among authors: narra r. Hematol Oncol. 2022 Feb;40(1):48-56. doi: 10.1002/hon.2946. Epub 2021 Nov 20. Hematol Oncol. 2022. PMID: 34763367

5

The changing spectrum of infection with BCMA and GPRC5D targeting bispecific antibody (bsAb) therapy in patients with relapsed refractory multiple myeloma.

Hammons L, Szabo A, Janardan A, Bhatlapenumarthi V, Annyapu E, Dhakal B, Al Hadidi S, Radhakrishnan SV, Narra R, Bhutani D, Thanendrarajan S, Janz S, Zangari M, Lentzsch S, Van Rhee F, Crescencio JCR, D'Souza A, Chakraborty R, Mohan M, Schinke C. Hammons L, et al. Among authors: narra r. Haematologica. 2024 Mar 1;109(3):906-914. doi: 10.3324/haematol.2023.283590. Haematologica. 2024. PMID: 37646658 Free PMC article.

6

Racial and Ethnic Disparities in Autologous Hematopoietic Cell Transplantation Utilization in Multiple Myeloma Have Persisted Over Time Even After Referral to a Transplant Center.

Wu JF, Estrada-Merly N, Dhakal B, Mohan M, Narra RK, Pasquini MC, D'Souza A. Wu JF, et al. Among authors: narra rk. Transplant Cell Ther. 2024 Dec;30(12):1189.e1-1189.e10. doi: 10.1016/j.jtct.2024.09.010. Epub 2024 Sep 12. Transplant Cell Ther. 2024. PMID: 39277111

7

Direct HLA Genetic Comparisons Identify Highly Matched Unrelated Donor-Recipient Pairs with Improved Transplantation Outcome.

Vazirabad I, Chhabra S, Nytes J, Mehra V, Narra RK, Szabo A, Jerkins JH, Dhakal B, Hari P, Anderson MW. Vazirabad I, et al. Biol Blood Marrow Transplant. 2019 May;25(5):921-931. doi: 10.1016/j.bbmt.2018.12.006. Epub 2018 Dec 8. Biol Blood Marrow Transplant. 2019. PMID: 30537549 Free article.

8

Human Leukocyte Antigen Class I Antibodies and Response to Platelet Transfusion in Patients Undergoing Liver Transplantation.

Wong M, Narra R, Selim M, Zimmerman MA, Kim J, Padmanabhan A, Hong JC. Wong M, et al. Among authors: narra r. J Surg Res. 2020 Nov;255:99-105. doi: 10.1016/j.jss.2020.05.029. Epub 2020 Jun 16. J Surg Res. 2020. PMID: 32543385

9

Fludarabine/Busulfan Conditioning-Based Allogeneic Hematopoietic Cell Transplantation for Myelofibrosis: Role of Ruxolitinib in Improving Survival Outcomes.

Chhabra S, Narra RK, Wu R, Szabo A, George G, Michaelis LC, D'Souza A, Dhakal B, Drobyski WR, Fenske TS, Jerkins JH, Pasquini MC, Rizzo RD, Saber W, Shah NN, Shaw BE, Hamadani M, Hari PN. Chhabra S, et al. Among authors: narra rk. Biol Blood Marrow Transplant. 2020 May;26(5):893-901. doi: 10.1016/j.bbmt.2020.01.010. Epub 2020 Jan 23. Biol Blood Marrow Transplant. 2020. PMID: 31982543 Free article.

10

Chronic Myeloid Leukemia-the Promise of Tyrosine Kinase Inhibitor Discontinuation.

Narra RK, Flynn KE, Atallah E. Narra RK, et al. Curr Hematol Malig Rep. 2017 Oct;12(5):415-423. doi: 10.1007/s11899-017-0404-z. Curr Hematol Malig Rep. 2017. PMID: 28944397 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

73 results

Search Page

Filters